Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
BARICITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN AN OPEN-LABEL, LONG-TERM EXTENSION STUDY Taylor, P., Genovese, M., Keystone, E., Schlichting, D., Beattie, S., Macias, W. BMJ PUBLISHING GROUP. 2014: A31
View details for DOI 10.1136/annrheumdis-2013-205124.71
View details for Web of Science ID 000346248400072